Axonics | 8-K: Current report
Apr 4 08:00 ET
Axonics | 8-K: Current report
Mar 25 16:04 ET
Axonics | DEFA14A: Others
Mar 7 17:26 ET
Axonics | 10-K: Annual report
Feb 29 14:19 ET
Axonics | 8-K: Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Feb 28 16:10 ET
Axonics | DEFM14A: Definitive proxy statement relating to merger or acquisition
Feb 22 08:01 ET
Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.38%)
Feb 13 17:09 ET
Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.322%),Abigail P. Johnson(2.322%)
Feb 12 12:05 ET
Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.710%),Abigail P. Johnson(10.710%)
Feb 9 08:39 ET
Axonics | PREM14A: Preliminary proxy statements relating to merger or acquisition
Feb 7 14:34 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Sama Rinda
Feb 2 18:02 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Noblett Karen
Feb 2 18:01 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Woock John
Feb 2 18:01 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Ford Alfred J Jr
Feb 2 18:01 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Keese Kari Leigh
Feb 2 18:01 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer COHEN RAYMOND W
Feb 2 18:01 ET
Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)
Jan 25 17:01 ET
Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Noblett Karen
Jan 10 00:00 ET
Axonics | DEF 14A: Definitive information statements
Jan 8 00:00 ET
Axonics | 8-K: Current report
Jan 8 00:00 ET
No Data
No Data